Abstract

3D Printing with Continuous Fibre reinforcement 
This speech gives insights into the Continuous Fibre Co-Extrusion technology. It discusses the technology and focusses on Fibre placement driven by simulation results to position fibre only at the point of need. It also discusses the usage of AI to help finding best in class solutions. It closes in showcasing dedicated applications and outcomes. 

Biography

Lutz Feldmann Vice President EMEA at FibreSeek Lutz graduated with a Diploma in Plastics Engineering back in 1988 in Darmstadt and followed the 3D Printing Industry since then. For over 25 years he hold senior positions at SolidWorks and Dassault Systemes and was always closely attached to engineering and design. The last six years Lutz is managing the channel partners for major 3D Printing vendors, specializing in the field of continuous fiber supported composite printing. In his current role he is building up a channel ecosystem for FibreSeek .

Abstract

From Imaging to Impact: Medical and Healthcare Applications of 3D Printing

Three-dimensional (3D) printing offers a practical pathway for translating medical imaging and clinical needs into personalized tools for patient care, education, research, and hospital operations. Drawing on multidisciplinary projects at Tampa General Hospital and the University of South Florida, this lecture explores how hospital-based additive manufacturing can connect digital planning with tangible healthcare applications.

The presentation follows the workflow from image acquisition and anatomical segmentation to virtual surgical planning, design, fabrication, and application-specific validation. Clinical examples include anatomical models for complex surgical planning, patient-specific cutting guides, and craniomaxillofacial reconstruction technologies. In-house design of patient-specific PEEK implants, with external manufacturing, illustrates how digital expertise and production partnerships can complement point-of-care capabilities.

Beyond surgical applications, the lecture highlights projects addressing patient engagement, clinical training, and operational challenges. The “Meet Your Heart” initiative offers transplant recipients a personalized model of their heart, combining patient education with a meaningful keepsake. A spina bifida repair simulator and maxillofacial nerve-block training models demonstrate applications in procedural education. Custom blood-bank cooler inserts illustrate how targeted design can address blood-product waste and create opportunities for measurable operational and economic improvement.

Emerging directions include artificial intelligence–assisted anatomical landmark identification, automated surgical planning tools, and patient-specific device design, with an emphasis on connecting imaging, planning, and manufacturing within more reproducible workflows. Implementation considerations include interdisciplinary collaboration, material selection, quality assurance, regulatory requirements, workflow integration, and evaluation of clinical and economic value.

By connecting clinical care, research, and education, this presentation provides a practical framework for identifying meaningful use cases, developing collaborative workflows, and assessing the impact of 3D printing beyond the printed object. 

Biography

Dr. Devid Zille is a Brazilian-trained maxillofacial surgeon and expert in medical 3D printing, virtual surgical planning, and additive manufacturing. He serves as Director of the Medical Visualization and Printing Lab at Tampa General Hospital and Assistant Professor in the Department of Radiology at the University of South Florida’s Morsani College of Medicine, leading clinical, research, and educational programs. He previously established and directed the additive manufacturing laboratory at Hospital Sírio-Libanês and held leadership positions at CPMH, Acumed, and Osteomed. He earned his dental degree with honors from the University of Brasília, completed a maxillofacial surgery residency at Base Hospital in Brasília, and undertook training at John Peter Smith Hospital in Texas. His contributions include scientific publications, patents and innovations in patient-specific implants and surgical guides.

Abstract

Nanomedicine is the use of nanomaterials to improve disease prevention, detection, and treatment which has resulted in hundreds of FDA approved medical products. While nanomedicine has been around for several decades, new technological advances are pushing its boundaries. For example, this presentation will present an over 30 year journey of commercializing nanomaterials for orthopedic implants now in over 45,000 patients to date showing no signs of failure. Current orthopedic implants face a failure rate of 5 – 10% and sometimes as high as 60% for bone cancer patients. Further, this talk will present future research directions into using atomic layer deposition (ALD) to create such nanostructures on implants to reduce infection and improve bone growth. Sensors grown off of orthopedic implants using ALD will also be discussed in which cell presence on orthopedic implants can be detected and quantified. Such information can also be communicated to a handheld device to better inform surgeons on chances of implant success or failure. Such sensors can also release pharmaceutical agents and/or nanoparticles on-demand to ensure implant success. Lastly, this talk will cover how Artificial Intelligence (AI) can be combined into today’s orthopedic implants to predict implant success or failure in the years that follow.

Biography

Thomas J. Webster’s (H index: 139) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has formed over a dozen companies who have numerous FDA approved medical products currently improving human health in over 45,000 patients. He is currently helping those companies and serves as a professor at Brown University, Saveetha University, Hebei University of Technology, UFPI, University of the Basque Country, and others. Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies. Prof. Webster is a former President of the U.S. Society for Biomaterials and has over 1,350 publications to his credit with over 55,000 citations. He was recently nominated for the Nobel Prize in Chemistry. Prof. Webster also recently formed a fund to support Nigerian student research opportunities in the U.S.